 |
National HIV/AIDS Program |  | | |
| Rescriptor
(delavirdine)
- Type of Drug: Nonnucleoside Reverse Transcriptase Inhibitor
-
Nonnucleoside reverse transcriptase inhibitors prevent HIV from using an enzyme called reverse transcriptase to make copies of itself. These drugs are also known as NNRTIs, nonnucleosides or "nonnukes."
Notes on taking this medication- No food restrictions, can take with or without food
- Rescriptor interacts with many other drugs; persons using Rescriptor with those drugs may need an adjustment to their dose of Rescriptor or the other drugs; consult your medical provider
Side effects- Rash (usually occurs within first 3 weeks of starting drug)
- Liver inflammation and increased liver enzyme levels
- Headache; fatigue; stomach upset
See accompanying chart: Tips for Common Side Effects My doctor's instructionsDisclaimer:This information is not meant to substitute for advice from your medical provider or pharmacist. If you have any questions about your medication dosing, talk to your medical provider or pharmacist. Image of Rescriptor is courtesy of T. Van Nunnery | | | |
|
| | |
|
| Reviewed/Updated Date: September 28, 2008 |
|
